This inventor holds 1 USPTO granted patent. Top assignee: Chung Ang University Industry Academic Cooperation. Active years: 2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018
Title: Kwang Sic Joo: Innovator in Glaucoma Treatment
Introduction
Kwang Sic Joo is a notable inventor based in Seoul, South Korea. He has made significant contributions to the field of ophthalmology, particularly in the treatment of glaucoma. His innovative approach has the potential to improve the quality of life for many individuals suffering from this condition.
Latest Patents
Kwang Sic Joo holds a patent for a pharmaceutical composition that utilizes angiogenin for the prevention or treatment of glaucoma. The patent describes how angiogenin or its fragments can activate aqueous humor outflow, leading to a reduction in intraocular pressure. This innovative treatment method represents a promising advancement in glaucoma therapy.
Career Highlights
Kwang Sic Joo is affiliated with Chung Ang University Industry Academic Cooperation, where he continues to engage in research and development. His work focuses on creating effective solutions for eye-related health issues, particularly glaucoma.
Collaborations
He collaborates with esteemed colleagues, including Jae Chan Kim and Doo Hwan Oh, to further enhance the research and development of innovative treatments.
Conclusion
Kwang Sic Joo's contributions to glaucoma treatment through his patent on angiogenin highlight his role as a significant inventor in the field. His work not only showcases his expertise but also offers hope for improved therapeutic options for patients.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile